Advertisement
Organisation › Details
Cardiorentis AG
Cardiorentis is a private biopharmaceutical company headquartered in Zug, Switzerland. Cardiorentis is committed to bringing novel therapies to the treatment of heart failure and related cardiovascular diseases. The company's disease-based technology platform integrates expertise in protein biology to identify novel targets and rationally design small molecule compounds and peptides for markets with unmet medical needs. *
Start | 2010-01-01 established | |
Group | Cardiorentis (Group) | |
Industry | cardiovascular drug | |
Industry 2 | ularitide | |
Person | Holzmeister, Johannes (Dinaqor 202009 CEO + Co-Founder + Cardiorentis AG 201409 CEO + CMO) | |
Person 2 | Schnee, Elmar (Cardiorentis 201110– CEO before Merck Serono S.A. 200701 CEO before Merck KGaA) | |
Region | Zug ZG | |
Country | Switzerland | |
Street | 74 Steinhauserstr. | |
City | 6300 Zug ZG | |
Tel | +41-41-748-6030 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2023-07-10 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top